Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
After 1 month washout period, intervention group and control group cross over for next 6 months.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Active surveillance test and preemptive isolation is performed. If MDRO is isolated in surveillance test, contact precaution is needed. |
|
| Control | Active Comparator | No active surveillance test and preemptive isolation performed. Only standard precaution is needed, and if clinical isolates reveals MDRO, start contact precaution. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Active surveillance and preemptive isolation | Other | Active surveillance test and preemptive isolation is performed. If MDRO is isolated in surveillance test, contact precaution is needed. |
| Measure | Description | Time Frame |
|---|---|---|
| The number of patients who acquired MDRGNB in ICU per 1000 patient-days | The number of patients who acquired MDRGNB in ICU per 1000 patient-days | through study completion, an average 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of bloodstream infection due to MDRGNB | Rate of bloodstream infection due to MDRGNB | through study completion, an average 6 months |
| Hand hygiene compliance rates (%) of healthcare workers |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jiwon Jung, MD | Contact | 82-10-3010-5041 | trueblue27@naver.com | |
| Sung-Han Kim, MD | Contact | 82-10-3010-3305 | kimsunghanmd@hotmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Asan Medical Center | Recruiting | Seoul | 05505 | South Korea |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36869371 | Derived | Jung J, Park JH, Yang H, Lim YJ, Kim EO, Lim CM, Kim MN, Jo MW, Yun SC, Kim SH. Active surveillance testing to reduce transmission of carbapenem-resistant, gram-negative bacteria in intensive care units: a pragmatic, randomized cross-over trial. Antimicrob Resist Infect Control. 2023 Mar 3;12(1):16. doi: 10.1186/s13756-023-01222-2. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D057832 | Watchful Waiting |
| ID | Term |
|---|---|
| D017063 | Outcome Assessment, Health Care |
| D010043 | Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Control | Other | No active surveillance and preemptive isolation. If clinical isolates are positive for MDRGNB, start contact precaution |
|
number of Hand hygiene compliance/number of opportunicities for hand hygiene of healthcare workers *100
| through study completion, an average 1 year |
| Days of ICU stay | Days of ICU stay | through study completion, an average 6 months |
| 28-day mortality rate | 28-day mortality rate | 28-days |